Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1128

Oct 8, 2021

How COVID is changing data analytics

Posted by in categories: biotech/medical, business, robotics/AI

Analytics has played a significant role in the fight against COVID-19. Would we be as far along in the battle without it?

The COVID-19 pandemic has changed many things in business, producing a new normal that all of us now operate in—and analytics is no exception.

“As companies adapt to the new normal created by COVID, one of the primary questions we’re asked in analytics is how to retrain artificial intelligence (AI) models with a more diverse data set,” said David Tareen, director of AI and analytics at SAS.

Oct 8, 2021

Scientists pinpoint evolutionary genes that allow lizards to give birth like mammals

Posted by in categories: biotech/medical, evolution

Dr. Hans Recknagel, who led the field and genome research during his Ph.D. and postdoctoral research, said: This was fascinating research, not least because in this species of lizard egg-laying populations still occur and interbreed with live-bearing ones.


Scientists studying the evolution of birth in lizards, from egg-laying to live births, have pinpointed the evolutionary genes from which the species is evolving to ‘build’ a new mode of reproduction.

The study—led by the University of Glasgow and published in Nature Ecology and Evolution —found that a significantly similar amount of the same genes involved in the pregnancy of lizards were shared with other mammals and live-bearing vertebrates.

Continue reading “Scientists pinpoint evolutionary genes that allow lizards to give birth like mammals” »

Oct 8, 2021

Merck Sells Federally Financed Covid Pill to U.S. for 40 Times What It Costs to Make

Posted by in categories: biotech/medical, government, health

A FIVE-DAY COURSE of molnupiravir, the new medicine being hailed as a “huge advance” in the treatment of Covid-19, costs $17.74 to produce, according to a report (pdf) issued last week by drug pricing experts at the Harvard School of Public Health and King’s College Hospital in London. Merck is charging the U.S. government $712 for the same amount of medicine, or 40 times the price. (taxpayer funded mind you)


The Covid-19 treatment molnupiravir was developed using funding from the National Institutes of Health and the Department of Defense.

Oct 8, 2021

‘Gut bugs’ can drive prostate cancer growth and treatment resistance

Posted by in categories: biotech/medical, genetics

Scientists also analysed microbial genetic material from the stool of men with prostate cancer and identified a specific bacterium – Ruminococcus – that may play a major role in the development of resistance. In contrast, the bacterium Prevotella stercorea was associated with favourable clinical outcomes.


Image: Section of a mouse gut. Credit: Kevin Mackenzie, University of Aberdeen.

Common gut bacteria can fuel the growth of prostate cancers and allow them to evade the effects of treatment, a new study finds.

Continue reading “‘Gut bugs’ can drive prostate cancer growth and treatment resistance” »

Oct 8, 2021

Regenerating the cells that keep the heart beating

Posted by in category: biotech/medical

Specialized cells that conduct electricity to keep the heart beating have a previously unrecognized ability to regenerate in the days after birth, a new study in mice by UT Southwestern researchers suggests. The finding, published online in the Journal of Clinical Investigation, could eventually lead to treatments for heart rhythm disorders that avoid the need for invasive pacemakers or drugs by instead encouraging the heart to heal itself.

“Patients with arrhythmias don’t have a lot of great options,” said study leader Nikhil V. Munshi, M.D., Ph.D., a cardiologist and Associate Professor of Internal Medicine, Molecular Biology, and in the Eugene McDermott Center for Human Growth and Development. “Our findings suggest that someday we may be able to elicit regeneration from the heart itself to treat these conditions.”

Dr. Munshi studies the cardiac conduction system, an interconnected system of specialized that generate electrical impulses and transmit these impulses to make the heart beat. Although studies have shown that nonconducting heart muscle cells have some regenerative capacity for a limited time after birth—with many discoveries in this field led by UTSW scientists—conducting cells called nodal cells were largely thought to lose this ability during the fetal period.

Oct 7, 2021

Coronavirus report warned of impact on UK four years before pandemic

Posted by in categories: biotech/medical, government, health, surveillance

Exclusive: Report from planning exercise in 2016 alerted government of need to stockpile PPE and set up contact tracing system.

Oct 7, 2021

An ultra detailed map of the brain region that controls movement, from mice to monkeys to humans

Posted by in categories: biotech/medical, health, neuroscience

It probably didn’t feel like much, but that simple kind of motion required the concerted effort of millions of different neurons in several regions of your brain, followed by signals sent at 200 mph from your brain to your spinal cord and then to the muscles that contracted to move your arm.

At the cellular level, that quick motion is a highly complicated process and, like most things that involve the human brain, scientists don’t fully understand how it all comes together.

Continue reading “An ultra detailed map of the brain region that controls movement, from mice to monkeys to humans” »

Oct 7, 2021

DeepMind Introduces ‘Enformer’, A Deep Learning Architecture For Predicting Gene Expression From DNA Sequence

Posted by in categories: biotech/medical, genetics, robotics/AI

DNA contains the genetic information that influences everything from eye color to illness and disorder susceptibility. Genes, which are around 20,000 pieces of DNA in the human body, perform various vital tasks in our cells. Despite this, these genes comprise up less than 2% of the genome. The remaining base pairs in the genome are referred to as “non-coding.” They include less well-understood instructions on when and where genes should be created or expressed in the human body.

DeepMind, in collaboration with their Alphabet colleagues at Calico, introduces Enformer, a neural network architecture that accurately predicts gene expression from DNA sequences.

Earlier studies on gene expression used convolutional neural networks as key building blocks. However, their accuracy and usefulness have been hampered by problems in modeling the influence of distal enhancers on gene expression. The proposed new method is based on Basenji2, a program that can predict regulatory activity from DNA sequences of up to 40,000 base pairs.

Oct 7, 2021

Cruise CEO Shows Off Locker Module And Wheelchair Accessible Origin Robotaxi

Posted by in categories: biotech/medical, business, food

In January 2,020 at the event where General Motors automated driving division Cruise took the wraps off the Origin robotaxi, a slide briefly appeared in the presentation showing a version of the vehicle for package deliveries. Today during the General Motors investor day, Cruise CEO Dan Ammann provided more details about the company’s business model and revenue opportunities and showed both a delivery module and a wheelchair accessible version.

Cruise has been providing automated deliveries in partnership with Walmart WMT +0.7% in the Phoenix area since late 2020. Throughout much of last year during the worst early phases of the pandemic in the San Francisco area, Cruise vehicles were used to provide more than 50,000 food deliveries to medical personnel and those in need. Those efforts have all utilized the current test fleet of Chevrolet Bolts which are not optimized for goods delivery.

Oct 7, 2021

Enabling AI-driven health advances without sacrificing patient privacy

Posted by in categories: biotech/medical, encryption, health, information science, robotics/AI

There’s a lot of excitement at the intersection of artificial intelligence and health care. AI has already been used to improve disease treatment and detection, discover promising new drugs, identify links between genes and diseases, and more.

By analyzing large datasets and finding patterns, virtually any new algorithm has the potential to help patients — AI researchers just need access to the right data to train and test those algorithms. Hospitals, understandably, are hesitant to share sensitive patient information with research teams. When they do share data, it’s difficult to verify that researchers are only using the data they need and deleting it after they’re done.

Secure AI Labs (SAIL) is addressing those problems with a technology that lets AI algorithms run on encrypted datasets that never leave the data owner’s system. Health care organizations can control how their datasets are used, while researchers can protect the confidentiality of their models and search queries. Neither party needs to see the data or the model to collaborate.